Cancer Drug Supplier’s IPO Mints China’s Latest Billionaire

Today’s listing at the Shanghai Stock Exchange by Sichuan Biokin Pharmaceutical, a supplier of cancer drugs, has minted China’s latest billionaire.

Chairman Zhu Yi directly owns 298.1 million shares, worth 10 billion yuan, or $1.5 billion in early afternoon trading. Shares rose 36% from their IPO price to 33.69 yuan.

Support authors and subscribe to content

This is premium stuff. Subscribe to read the entire article.

Gain access to all our Premium contents.
More than 100+ articles.

Subscribe Now

Buy Article

Unlock this article and gain permanent access to read it.

Unlock Now

Cancer Drug Supplier’s IPO Mints China’s Latest Billionaire

Related Articles

Pepsi: 1 App To Rule Them All, And In The Lightness Bind Them

Despite Turnover Issues, Josh Dobbs Deserves 1 More Start For Vikings

U2 Keeps Extending Their Concert Residency

Ukraine Has Formed A New Tank Brigade

Executive Sketch: Matheson Leads NRECA In Era of Big Change For Utilities

NASA’s Planned 2025 Moon Landing ‘Unlikely’ Amid SpaceX And Spacesuit Delays, Report Warns

2024 Political TV Advertising: We’re Ready To Project The Winners

Hamas Releases 2 Israeli-Russian Hostages In Outreach To Putin—As 6-Day Truce With Israel Nears End

Erik Ten Hag Challenges Facundo Pellistri To Step Up At Manchester United

Navigate Site

Welcome Back!

Retrieve your password

Are you sure want to unlock this post?

Are you sure want to cancel subscription?

Cancer Drug Supplier’s IPO Mints China’s Latest Billionaire

Support authors and subscribe to content

Subscribe

Buy Article

Related Articles

Navigate Site

Follow Us

Welcome Back!

Retrieve your password

Are you sure want to unlock this post?

Are you sure want to cancel subscription?